Large dose bolus intravenous methylprednisolone has been used to good effect in other autoimmune diseases -for example, glomerulonephritis'-3-and we therefore decided to try it in autoimmune ophthalmopathy. As Graves' ophthalmopathy is a nonfatal disease and intravenous methylprednisolone is itself not without risk, we cautiously employed a lower total dose schedule than has been used for either graft rejection or glomerulonephritis. This paper reports on 11 patients treated in this way, who were followed up for six months or more. Measurements were made of different aspects of the disease for statistical assessment and these compared with the changing serum autoantibody activities.
Patients and methods
The 11 patients (six women, five men) were aged 28-68 years (mean 52-6) and had had their eye disease for three to 72 months. Table I gives details of the patients at entry to the study. Only two patients had received any previous immunosuppressive treatment. All were euthyroid at the time treatment was begun and Visual acuity:
Normal (6/6) 15 19 6/9-6/18 (<0 9, >0 4t) (fig 2) . The mean measurement before treatment was 7-41 mm (SD 0-81) and six months after treatment the mean reading was 3 33 mm (0 50). Wilcoxon's signed rank test showed that the improvement after eight weeks was not significant but that after 12 weeks it was significant at 5% and after six months it was significant at 1%. When measurements in right and left eyes were averaged for each patient the values before and after treatment were 6 41 mm and 3 25 mm respectively. Inflammatory signs consisting of lid oedema, conjunctival oedema, and injection over the insertions of the horizontal recti were present in 10 patients at the initial examination. After treatment nine patients showed a substantial improvement, particularly in relation to conjunctival injection and oedema and injection over the muscle insertions. There was some diminution of periorbital oedema, but this was complicated in most cases by fat herniation into the upper lids in particular.
Five patients showed pronounced muscle dysfunction in both horizontal and vertical movements. After the treatment period three patients showed an improvement in muscle function with loss of diplopia. Two patients, however, remained unchanged and required extraocular muscle surgery. 21, p<0003) and with exophthalmos (r,=047, p<O-OOO1).
NEURORADIOLOGICAL ASSESSMENT
Nine patients had CT scans before and after treatment. All the scans were abnormal before treatment with varying degrees of enlargement of one or more extraocular muscles. The medial rectus muscles were affected most commonly, whereas the lateral rectus muscles were enlarged in only three patients. In all but one of these nine cases there was a definite reduction in muscle size, though the degree of improvement was variable. The mean scores before and after treatment were 8-0 (SEM 1-4) and 3 9 (SEM' 0 9) respectively. In only one patient (case 2; fig 3) did extraocular muscle size return completely to normal after severe enlargement (pretreatment score 13).
ADVERSE EFFECTS
Adverse effects were a weight gain of around 3 kg in four patients, transient impairment of glucose tolerance in one, mild dyspepsia in one, and irritability in one.
Discussion
In this series of 11 patients treated with intravenous methylprednisolone for severe Graves' eye disease three patients who had had their disease for more than a year showed little or no response. The remaining patients showed an overall clear cut response, which was most apparent from measurements of the intraocular pressure differential and visual acuity. The response was often quite dramatic by 24 hours after the first dose, both when assessed subjectively and when evaluated objectively; this was most noticeable as a decrease in inflammation and proptosis with an improvement in visual acuity and therefore possibly represented a decrease in orbital oedema rather than immunosuppression at that stage. We decided to evaluate the late response, as the long term result is the more important; but for patients with congestive ophthalmopathy, fortunately rare (case 5), the ability to obtain rapid improvement is plainly an advantage.
There are two main problems in designing a trial of treatment of Graves' ophthalmopathy-namely, FIG 3-Case 2. Coronal plane CT scans through posterior orbit before (left) and six months after treatment with methylprednisolone (right). Second scan shows pronounced reduction in extraocular muscle size selecting the most appropriate method of assessment and the impossibility of doing a properly controlled trial. Other studies have used an arbitrary index to assess response,7 but we do not think that this is appropriate, as it gives equal weighting to several variables, some of which are less important than others. The most important aspects of treatment are in restoring normal visual acuity, avoiding corneal exposure, and improving double vision. Cosmetic improvement is of secondary importance in the acute phase and is better dealt with surgically later. It therefore follows that the best measures of severity of the disease and of response to treatment are visual acuity and muscle function (Hess chart, intraocular pressure differential, and possibly fields of binocular single vision).
Vertical palpebral aperture does not reflect well the degree of ophthalmopathy, partly because of the difficulty in obtaining an accurate measurement8 and also because it is affected by other factors, such as thyroid state, which are independent of true ophthalmopathy. Proptosis, though a more useful measure, is also of limited value and does not necessarily relate to the severity of visual impairment.9
The intraocular pressure differential has been considered useful by other workers'0'2 and is a more sensitive method of detecting Graves' ophthalmopathy than measurement of exophthalmos. " Our study shows the usefulness of the intraocular pressure differential in determining response to treatment, and it also correlated well with the patients' own assessments.
It is clear that intravenous methylprednisolone is effective, but it is less easy to make definite recommendations about its place in the treatment of Graves' ophthalmopathy. As ophthalmopathy severe enough to warrant immunosuppressive treatment occurs in only 2-3% of patients with Graves' disease direct comparisons with high dose oral steroids or with cyclosporin would require large scale multicentre trials. We find, however, that oral steroids are of only moderate efficacy; they have delayed effects and frequent adverse effects. This also appears to be the experience of others,'314 and many workers have commented on the need for prolonged high dosage with the attendant risks of potentially serious side effects. By using intravenous bolus methylprednisolone a highly immunosuppressive dose of steroid can be given with a considerably reduced risk of adverse effects. Experience with cyclosporin,'5 plasma exchange,2 16 and other immunosuppressive drugs is less satisfactory.'7 An alternative approach to treatment is with orbital cobalt radiotherapy, total dose 20 Gy (2000 rads), combined with systemic steroids (70-80 mg prednisolone daily for several weeks). 14 18 We do not know the precise cause of Graves' ophthalmopathy, though there is good evidence that it results from an autoimmune process. ' 
Introduction
Many parts of the human body are projected in the brain.' Some people believe that projection also exists in other organs-for example, the tongue, feet, ears.' In 1881 von Nczely wrote a book on diagnosis using the eye, in which he gave a schematic representation of the topography of the organs in the iris. Some people now believe that many diseases manifest themselves in the iris,3 which is supposed to indicate not only the existence of certain diseases but also the tendency for their development ("constitution"). Iridology is practised on a large scale especially in alternative medicine, in which it is considered to be an important diagnostic supplement to the medical history and (conventional) physical examination.
The emphasis of this study was on the validity of iridology and on consistency among iridologists. Because using iridology is doubted on both theoretical and empirical grounds34 I chose a simple test: to study patients with an obvious disease that according to iridologists cannot be overlooked-namely gall stones
